Remove GlobalData Healthcare
article thumbnail

Brexit fallout continues with batch testing concerns

Pharmaceutical Technology

According to a 2021 GlobalData survey, Brexit is expected to have a worse impact on the UK’s healthcare sector than the Covid-19 pandemic. Mark Samuels, chief executive of the British Generic Manufacturers Association (BGMA) remarked that these duplicative processes would add time and cost. “We

Medicine 290
article thumbnail

The Brazilian pharma market: Key information and what may change

Pharmaceutical Technology

This size alone brings significant benefits to its citizens, with Brazil having a publicly funded and government-run healthcare system offering free and universal access to healthcare for the entire population. Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Free Whitepaper.

Marketing 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. By GlobalData. United Kingdom. United States. Afghanistan.

Doctors 242
article thumbnail

Legal challenges put off label use of gender affirming care drugs in jeopardy

Pharmaceutical Technology

Dr Lisa Campo-Engelstein, a bioethicist, predicts that these factors and subsequent restrictions on statewide healthcare coverage will heavily restrict patient access to gender-affirming care. Campo-Engelstein is the director of the Institute for Bioethics & Health Humanities at the University of Texas Medical Branch, Galveston.

Drugs 360